Literature DB >> 2005479

Primary care and HIV disease.

M D Smith1.   

Abstract

Nearly one million Americans are infected with the human immunodeficiency virus (HIV). With the advent of increasingly effective therapy, including intervention early in the course of infection, there will be a growing need for physicians technically and attitudinally prepared to provide primary care for HIV-infected individuals. For any disease, however, determination of which physicians provide the bulk of care depends on several factors, including the prevalence and chronicity of the disease, the complexity, rate of change, and toxicity of therapy, and the socioeconomic characteristics of patients with the disease. General internists will clearly constitute a large part of the pool of practitioners caring for HIV-infected patients, especially in the earlier stages of infection. It seems reasonable to expect every general internist to be competent in four aspects of HIV care: counseling about transmission and prevention; the proper administration and interpretation of diagnostic tests; monitoring and care of patients in early stages of infection; and recognition of complications of advanced infection for proper management or referral. Academically based generalists will have a major role in research, teaching, and patient care in the AIDS epidemic. The organization and delivery of primary and specialty care for HIV-infected people in future years will continue to evolve with changes in therapy and in the demography of the epidemic.

Entities:  

Mesh:

Year:  1991        PMID: 2005479     DOI: 10.1007/bf02599259

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  24 in total

1.  Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex.

Authors:  A W Wu; W C Mathews; L T Brysk; J H Atkinson; I Grant; I Abramson; C J Kennedy; J A McCutchan; S A Spector; D D Richman
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

2.  Physician contact with and attitudes toward HIV-seropositive patients. Results from a national survey.

Authors:  J A Rizzo; W D Marder; R J Willke
Journal:  Med Care       Date:  1990-03       Impact factor: 2.983

3.  The HIV epidemic and training in internal medicine. Challenges and recommendations.

Authors:  M Cooke; M A Sande
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

4.  Going home to die: developing home health care services for AIDS patients.

Authors:  T Droste
Journal:  Hospitals       Date:  1987-08-20

Review 5.  Paying the medical cost of the HIV epidemic: a review of policy options.

Authors:  H J Makadon; G R Seage; K E Thorpe; H V Fineberg
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

6.  The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.

Authors:  C Pedersen; E Sandström; C S Petersen; G Norkrans; J Gerstoft; A Karlsson; K C Christensen; C Håkansson; P O Pehrson; J O Nielsen
Journal:  N Engl J Med       Date:  1990-06-21       Impact factor: 91.245

7.  Stigmatization of AIDS patients by physicians.

Authors:  J A Kelly; J S St Lawrence; S Smith; H V Hood; D J Cook
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

8.  Compulsory premarital screening for the human immunodeficiency virus. Technical and public health considerations.

Authors:  P D Cleary; M J Barry; K H Mayer; A M Brandt; L Gostin; H V Fineberg
Journal:  JAMA       Date:  1987-10-02       Impact factor: 56.272

9.  The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Authors:  M A Fischl; D D Richman; N Hansen; A C Collier; J T Carey; M F Para; W D Hardy; R Dolin; W G Powderly; J D Allan
Journal:  Ann Intern Med       Date:  1990-05-15       Impact factor: 25.391

10.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

View more
  6 in total

Review 1.  Physicians and AIDS: sexual risk assessment of patients and willingness to treat HIV-infected patients.

Authors:  B Gerbert; T Bleecker; B T Maguire; N Caspers
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

2.  Quality in HIV/AIDS care. Specialty-related or experience-related?

Authors:  W C Holmes
Journal:  J Gen Intern Med       Date:  1997-03       Impact factor: 5.128

3.  Clinic services for persons with AIDS. Experience in a high-prevalence state.

Authors:  L E Markson; B J Turner; J Cocroft; R Houchens; T R Fanning
Journal:  J Gen Intern Med       Date:  1997-03       Impact factor: 5.128

4.  Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program.

Authors:  P A Selwyn; N S Budner; W C Wasserman; P S Arno
Journal:  Public Health Rep       Date:  1993 Jul-Aug       Impact factor: 2.792

5.  The ambulatory care of HIV-infected persons: a survey of physician practice patterns.

Authors:  M D Stein; P O'Sullivan; L Rubenstein; P Weller; T Wachtel
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

6.  Provider perceptions of key barriers to providing state-of-the-art clinical care for HIV-infected African-American patients.

Authors:  Wilhelmena Lee-Ougo; Bradley O Boekeloo; Estina E Thompson; Alen S Funnyé; Rudolph E Jackson; Gerard ShuTangyie; J I McNeil
Journal:  J Natl Med Assoc       Date:  2003-02       Impact factor: 1.798

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.